drugset / Trial / NCT01964365

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

NCT01964365

Phase 1 Completed 30 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and fenofibric acid in healthy adult subjects

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg
Subject fenofibric acid Small molecule 135 mg

Indications

No indication recorded.